Hudson Bay Capital Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
LGM
GP
Hudson Bay Capital Management's BNTX Position: Q2 2026 in Review
Hudson Bay Capital Management reduced its BioNTech (BNTX) stake by 5.5% in Q2 2026, selling an estimated $1.41M and leaving 260,000 shares worth $24.2M. The position accounts for 0.07% of the portfolio, ranked #199.
Hudson Bay Capital Management first reported a position in BNTX in Q1 2020 and has held it in 18 quarters since. The position peaked at $35.7M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.
- Hudson Bay Capital Management held 260,000 shares of BioNTech worth $24.2M as of Q2 2026.
- Hudson Bay Capital Management sold 15,000 BioNTech shares in Q2 2026, an estimated $1.41M.
- BioNTech made up 0.07% of Hudson Bay Capital Management's portfolio in Q2 2026, its #199 holding.
- Hudson Bay Capital Management first reported a position in BioNTech in Q1 2020 and has held it in 18 quarters since.
- Hudson Bay Capital Management's BioNTech position peaked at $35.7M in Q4 2025.
- 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.
Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.